Why the study?
Is C-fiber function altered in individuals with impaired glucose tolerance compared to those with type 1 diabetes and healthy controls?
Is C-fiber function altered in individuals with impaired glucose tolerance compared to those with type 1 diabetes and healthy controls?
Small-fiber neuropathy is a feature of impaired glucose tolerance but not longstanding type 1 diabetes, suggesting glycemia may not be the major determinant of small-fiber neuropathy in IGT.
Indicates early small-fiber neuropathy in IGT but not type 1 diabetes; leaves open non-glycemic mechanisms and requires longitudinal confirmation.
OBJECTIVE: This study explored the importance of glycemic burden compared with features of the metabolic syndrome in the pathogenesis of diabetic neuropathy by comparing C-fiber function in people with type 1 diabetes to that in people with impaired glucose tolerance (IGT). RESEARCH DESIGN AND METHODS: The axon reflex-elicited flare areas (LDIflares) were measured with a laser Doppler imager (LDI) in age-, height-, and BMI-matched groups with IGT (n = 14) and type 1 diabetes (n = 16) and in healthy control subjects (n = 16). RESULTS: The flare area was reduced in the IGT group compared with the control (2.78 +/- 1.1 vs. 5.23 +/- 1.7 cm(2), P = 0.0001) and type 1 diabetic (5.16 +/- 2.3 cm(2), P = 0.002) groups, whereas the flare area was similar in the type 1 diabetic and control groups. CONCLUSIONS: This technique suggests that small-fiber neuropathy is a feature of IGT. The absence of similar small-fiber neuropathy in those with longstanding type 1 diabetes suggests that glycemia may not be the major determinant of small-fiber neuropathy in IGT.
No takes yet. Share an insight, caveat, or question.
Green et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: